Xenon Pharmaceuticals Inc (XENE)

30.45 +0.10  +0.33% NASDAQ Oct 21, 12:59 USD

Xenon Pharmaceuticals Balance Sheet (Quarterly)

Export Data

June 2021 - March 2019

Previous Periods

Assets (Quarterly) 2021-06 2021-03 2020-12 2020-09 2020-06 2020-03 2019-12 2019-09 2019-06 2019-03
Cash and Equivalents Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Short Term Investments Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Cash and Short Term Investments 260.52M 274.70M 177.00M 190.93M 202.75M 229.67M 141.36M 94.60M 101.80M 110.43M
Accounts Receivable 2.919M 5.06M 1.822M 1.609M 1.786M 1.617M 0.813M 0.209M 0.171M 0.132M
Total Receivables Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Prepaid Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Current Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Properties Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Buildings and Improvements Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Machine, Furniture & Equipment Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Properties Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Leases Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Gross PP&E Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accumulated D&A Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Net PP&E Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Long Term Deferred Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Long Term Assets Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Assets 274.71M 290.67M 189.19M 199.13M 210.68M 237.04M 147.70M 98.90M 105.89M 114.55M
Liabilities (Quarterly) 2021-06 2021-03 2020-12 2020-09 2020-06 2020-03 2019-12 2019-09 2019-06 2019-03
Accounts Payable 3.278M 2.132M 3.041M 2.198M 1.633M 3.217M 2.473M 1.371M 1.498M 1.071M
Total Payables Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accrued Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Payables and Accrued Expenses Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Current Borrowings Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Portion of Long Term Debt Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Capital Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Debt & Capital Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Deferred Revenue Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Current Deferred Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Other Current Liability Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Current Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Portion of Long Term Debt Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Long Term Cap Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Portion of LTD and Capital Lease Obligation Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Deferred Revenue Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Non-Current Deferred Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Long Term Liabilities Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Total Liabilities 17.73M 14.39M 17.83M 17.10M 21.38M 49.06M 55.72M 24.34M 23.10M 22.24M
Shareholder's Equity (Quarterly) 2021-06 2021-03 2020-12 2020-09 2020-06 2020-03 2019-12 2019-09 2019-06 2019-03
Total Capital Stock Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Retained Earnings Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Additional Paid In Capital Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Preferred Stock Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Accrued Comprehensive Inc Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade Upgrade
Shareholders Equity 256.98M 276.28M 171.36M 182.02M 189.30M 187.98M 91.98M 74.56M 82.79M 92.31M
SEC Filing Links 2021-06 2021-03 2020-12 2020-09 2020-06 2020-03 2019-12 2019-09 2019-06 2019-03
As Originally Reported AOR AOR AOR AOR AOR AOR AOR AOR AOR AOR
Restated Restated Restated Restated Restated Restated Restated

June 2021 - March 2019

Previous Periods

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.